We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+19.27%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$203M
AUM Growth
+$17.5M
Cap. Flow
-$7.87M
Cap. Flow %
-3.87%
Top 10 Hldgs %
66.21%
Holding
70
New
5
Increased
15
Reduced
33
Closed
4

Top Buys

Rank Stock Value
1
EMKR
Emcore Corp
EMKR
+$2.71M
2
XENT
Intersect ENT, Inc
XENT
+$2.36M
3
SPSC icon
SPS Commerce
SPSC
+$1.41M
4
VG
Vonage Holdings Corporation
VG
+$1.29M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$911K

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$10.2M
2
FNSR
Finisar Corp
FNSR
+$3.08M
3
CTCT
CONSTANT CONTACT, INC COM
CTCT
+$2.13M
4
STKL
SunOpta
STKL
+$753K
5
OCLR
Oclaro Inc.
OCLR
+$689K

Sector Composition

Rank Sector Weight
1 Technology 48.99%
2 Healthcare 40.39%
3 Financials 1.76%
4 Industrials 1.61%
5 Miscellaneous 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QCOM icon
51
Qualcomm
QCOM
$176B
$593K 0.29%
11,865
-740
-6% -$39.5K
JWN
52
DELISTED
Nordstrom
JWN
$524K 0.26%
10,513
-2,275
-18% -$138K
IWO icon
53
iShares Russell 2000 Growth ETF
IWO
$15.1B
$498K 0.24%
+3,575
New +$507K
EGRX
54
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$475K 0.23%
5,358
– –
VTI icon
55
Vanguard Morningstar Total Stock Market ETF
VTI
$689B
$375K 0.18%
3,600
– –
VCSH icon
56
Vanguard Short-Term Corporate Bond ETF
VCSH
$45.1B
$316K 0.16%
4,000
– –
QQQ icon
57
Invesco QQQ Trust
QQQ
$493B
$302K 0.15%
2,700
– –
GE icon
58
GE Aerospace
GE
$356B
$253K 0.12%
+1,694
New +$241K
INTC icon
59
Intel
INTC
$487B
$229K 0.11%
6,644
– –
AAPL icon
60
Apple
AAPL
$4.59T
$214K 0.11%
8,120
+600
+8% +$17.1K
SBUX icon
61
Starbucks
SBUX
$122B
$213K 0.1%
3,550
-145
-4% -$8.83K
TVTY
62
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$201K 0.1%
15,590
– –
LXRX icon
63
Lexicon Pharmaceuticals
LXRX
$1.03B
$182K 0.09%
13,710
+1,690
+14% +$20.8K
EXAS
64
DELISTED
Exact Sciences
EXAS
$131K 0.06%
+14,140
New +$131K
VCYT icon
65
Veracyte
VCYT
$3.64B
$103K 0.05%
14,250
-26,160
-65% -$176K
AVDL
66
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-17,049
Closed -$278K
STKL
67
DELISTED
SunOpta
STKL
– –
-154,900
Closed -$753K
SUPN icon
68
Supernus Pharmaceuticals
SUPN
$2.57B
– –
-729,960
Closed -$10.2M
AVGR
69
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
0
– -$222K
SIEN
70
DELISTED
Sientra, Inc.
SIEN
– –
-2,391
Closed -$243K
1 2
3

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, Kopp Investment Advisors held 70 positions worth $203M, up 9.4% from $186M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Kopp Investment Advisors withdrew a net $7.87M in Q4 2015, closing 4 positions and reducing 33 holdings. Its most notable exit was Supernus Pharmaceuticals, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 45% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Kopp Investment Advisors opened a new position in SPS Commerce worth $1.35M.

  • Kopp Investment Advisors's largest Q4 2015 buy was SPS Commerce: 38,528 shares worth $1.35M.
  • Kopp Investment Advisors added most to Emcore Corp in Q4 2015, an estimated $2.71M increase.
  • Kopp Investment Advisors's biggest Q4 2015 reduction was Finisar Corp, cutting an estimated $3.08M.
  • Kopp Investment Advisors fully exited Supernus Pharmaceuticals in Q4 2015, selling an estimated $10.2M.
  • Kopp Investment Advisors's ten largest holdings make up 66% of its $203M portfolio in Q4 2015.
  • Kopp Investment Advisors opened 5 new positions and closed 4 in Q4 2015.
  • Kopp Investment Advisors's portfolio value rose 9.4% quarter-over-quarter to $203M.

Based on Kopp Investment Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.